Title
Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau-PET/MRI at 3T
Date Issued
01 January 2021
Access level
open access
Resource Type
journal article
Author(s)
Carlson M.L.
Toueg T.N.
Khalighi M.M.
Castillo J.
Shen B.
Azevedo E.C.
DiGiacomo P.
Mouchawar N.
Zaharchuk G.
James M.L.
Mormino E.C.
Zeineh M.M.
Stanford University
Publisher(s)
John Wiley and Sons Inc
Abstract
Introduction: Alzheimer's disease (AD) is the most common form of dementia, characterized primarily by abnormal aggregation of two proteins, tau and amyloid beta. We assessed tau pathology and white matter connectivity changes in subfields of the hippocampus simultaneously in vivo in AD. Methods: Twenty-four subjects were scanned using simultaneous time-of-flight 18F-PI-2620 tau positron emission tomography/3-Tesla magnetic resonance imaging and automated segmentation. Results: We observed extensive tau elevation in the entorhinal/perirhinal regions, intermediate tau elevation in cornu ammonis 1/subiculum, and an absence of tau elevation in the dentate gyrus, relative to controls. Diffusion tensor imaging showed parahippocampal gyral fractional anisotropy was lower in AD and mild cognitive impairment compared to controls and strongly correlated with early tau accumulation in the entorhinal and perirhinal cortices. Discussion: This study demonstrates the potential for quantifiable patterns of 18F-PI2620 binding in hippocampus subfields, accompanied by diffusion and volume metrics, to be valuable markers of AD.
Volume
13
Issue
1
Language
English
OCDE Knowledge area
Neurología clínica
Radiología, Medicina nuclear, Imágenes médicas
Subjects
Scopus EID
2-s2.0-85124326578
Source
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
ISSN of the container
23528729
Sponsor(s)
This work was funded by the National Science Foundation Graduate Research Fellowship under grant no. DGE‐1656518, NIA R01AG061120, R01 AG048076, K01 AG051718, R21 AG058859, American Society for Neuroradiology Boerger Research Fund for Alzheimer's Disease and Neurocognitive Disorders, Doris Duke Charitable Foundation, GE Healthcare, Stanford Wu Tsai Neuroscience Institute, and Stanford Precision Health and Integrated Diagnostics Center (PHIND). GZ declares royalties or licenses to him from Cambridge University Press and Stanford patents; he has also consulted for Biogen, received payment from AOCN and AOCNR, provided expert testimony to several legal firms, served on the board of trustees of ISMRM and Subtle Medical, which he cofounded. MC declares receiving a trainee award from ISMRM. GC declares receiving payment from MBCT at Stanford. MK declares patents on MR guided PET reconstruction methods. MJ declares serving on the board of directors of the World Molecular Imaging Society and Women in Molecular Imaging Network. EM declares receiving payments from Eli Lilly and Roche, and co‐chairs the NIA ADRC Imaging Core steering committee.
Sources of information:
Directorio de Producción Científica
Scopus